Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

In 2012, Buyer’s Market Made Alliances Rarer

Jan 07 2013

• By Paul Bonanos

Related Content

With Bristol/AstraZeneca In Driver’s Seat, GLP-1 Race Takes A Turn

Jul 09 2012

Intarcia Forgoes Partnerships, Raises $210M In Equity And Debt Instead

Nov 15 2012

Exelixis Defends Cancer Drug XL184 After Partner BMS Walks Out

Jun 21 2010

Bardoxolone Blow-Up: Reata/Abbott CKD Drug Halted In Phase III

Oct 18 2012

No Longer Aiming To Partner At Proof-of-Concept, Flexion Raises $20M For Late-Stage Trials

Dec 04 2012

Related Companies

Intarcia Therapeutics, Inc.

Flexion Therapeutics, Inc.

Eli Lilly and Company

Abbott

Reata Pharmaceuticals, Inc.

Bristol Myers Squibb Company

Exelixis, Inc.

AstraZeneca PLC

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Additional Topics

Business Strategies Deals Leadership BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window